Sep 13, 2022 / 03:00PM GMT
Sean Lee - H.C. Wainwright - Analyst
Good morning, everyone, and thank you for attending the H.C. Wainwright 24th Annual Global Healthcare Investment Conference. My name is Sean Lee, and I'm an equity research analyst at the bank. To this morning's presentation, I'd like to welcome Mr. Shai Novik, who is the Executive Chairman of Enlivex.
Shai Novik - Enlivex Therapeutics Ltd. - Executive Chairman
Thank you, Sean. Good morning, everyone. Again, Shai Novik, Executive Chairman of Enlivex. Thanks for joining for this presentation. So first of all, obviously, this presentation is governed by our forward-looking statements as detailed in the various filings with the SEC. So just a reminder to everybody in terms of positioning of where Enlivex is. Enlivex is a cell therapy company.
If you remember, the past of cell therapy is we go back to the, say, 2014 era, just like eight years ago with Kite and Juno and changing the world with engineered T-cells. But this was really more blood cancer focused and some limitations, including such like cells being autologous
Enlivex Therapeutics Ltd at H C Wainwright Global Investment Conference Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers